Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 0.0033113 | uM | 5 | 312.50 | 138.75 | 356.00 | 242.00 | 1.4711 | 2.2353 |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 5 | 312.50 | 138.75 | 326.00 | 242.00 | 1.3471 | 1.8992 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 5 | 312.50 | 138.75 | 124.00 | 242.00 | 0.5124 | -0.1307 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 5 | 312.50 | 138.75 | 136.00 | 242.00 | 0.5620 | -0.0246 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 269.00 | 242.00 | 1.1116 | 1.2818 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 198.00 | 242.00 | 0.8182 | 0.5575 | |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 525.00 | 729.75 | 0.7194 | 0.5414 | |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 618.00 | 729.75 | 0.8469 | 0.7536 | |
| SK-BR-3 | Etoposide | 10 | uM | 5 | 625.00 | 303.79 | 388.00 | 729.75 | 0.5317 | 0.2135 |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 903.00 | 729.75 | 1.2374 | 1.3670 | |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 759.00 | 729.75 | 1.0401 | 1.0631 | |
| SK-BR-3 | Etoposide | 1 | uM | 5 | 625.00 | 303.79 | 479.00 | 729.75 | 0.6564 | 0.4336 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 5 | 625.00 | 303.79 | 813.00 | 729.75 | 1.1141 | 1.1784 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 5 | 625.00 | 303.79 | 905.00 | 729.75 | 1.2402 | 1.3712 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 5 | 625.00 | 303.79 | 825.00 | 729.75 | 1.1305 | 1.2038 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 5 | 625.00 | 303.79 | 1207.00 | 729.75 | 1.6540 | 1.9777 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 5 | 625.00 | 303.79 | 920.00 | 729.75 | 1.2607 | 1.4022 |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 858.00 | 729.75 | 1.1757 | 1.2732 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 5 | 625.00 | 303.79 | 771.00 | 729.75 | 1.0565 | 1.0889 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 5 | 625.00 | 303.79 | 709.00 | 729.75 | 0.9716 | 0.9549 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 5 | 625.00 | 303.79 | 745.00 | 729.75 | 1.0209 | 1.0330 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 5 | 625.00 | 303.79 | 658.00 | 729.75 | 0.9017 | 0.8428 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 5 | 625.00 | 303.79 | 673.00 | 729.75 | 0.9222 | 0.8760 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 5 | 625.00 | 303.79 | 824.00 | 729.75 | 1.1292 | 1.2017 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 5 | 625.00 | 303.79 | 610.00 | 729.75 | 0.8359 | 0.7356 |